Thursday, January 30News That Matters

Tag: WHO

WHO Renames Monkeypox As ‘Mpox’
International news

WHO Renames Monkeypox As ‘Mpox’

The World Health Organization announced Monday that “mpox” is now the preferred name for monkeypox. “Both names will be used simultaneously for one year while ‘monkeypox’ is phased out,” the organization said. The Biden administration said they “welcome the change” and the US will use the mpox name “from this point forward.” Monkeypox was named in 1970, more than a decade after the virus that causes the disease was discovered in captive monkeys, the organization said. But monkeypox probably didn’t start in monkeys – its origin is still unknown – and the virus can be found in several other kinds of animals.  The name was created before WHO published best practices for naming diseases in 2015. Scientists and experts have pushed since the start of ...
WHO cautions against use of vaccine passports.
Travel

WHO cautions against use of vaccine passports.

The World Health Organisation (WHO) has advised countries against demanding proof that travellers have vaccinated against coronavirus. At present, proof of immunisation against diseases such as yellow fever is required at some international borders in accordance with the International Health Regulations.  The WHO said although there is evidence vaccination breaks the chain of transmission, the current inequity in distribution makes such requirements unfair and unethical. “Do not require proof of vaccination as a condition of entry, given the limited (although growing) evidence about the performance of vaccines in reducing transmission and the persistent inequity in the global vaccine distribution,” said a statement summarising the International Health Regulations Emergen...
AstraZeneca vaccine finds no evidence of blood clot risk.
Science

AstraZeneca vaccine finds no evidence of blood clot risk.

AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots. AstraZeneca’s review, which covered more than 17 million people vaccinated in the United Kingdom and European Union, comes after health authorities in some countries suspended the use of its vaccine over clotting issues. Authorities in Ireland, Denmark, Norway, Iceland and the Netherlands have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating a death from coagulation disorders. uropean Medicines Agency has said there is no indication that the events were caused by the vaccination, a view that was echoed by the World Health Organisa...